Class IITerminatedD-0736-2021
Drug recall · August 25, 2021
Octreotide Acetate Injection 1000 mcg/5mL recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3333-01
- Lots / codes
Lot #: 31329150B, exp. date 06/2022
- Quantity
- 16,644 vials
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Product was distributed Nationwide, including Puerto Rico.
- Initiated
- July 29, 2021 · Voluntary: Firm initiated
- Classified
- August 16, 2021
- Reported
- August 25, 2021
- Ended
- June 4, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedAug 25, 2021DAUNOrubicin Hydrochloride Injection 20 mg/4mLTeva Pharmaceuticals USA · D-0730-2021Class IITerminatedAug 25, 2021Methylprednisolone Acetate Injectable Suspension USPTeva Pharmaceuticals USA · D-0731-2021Class IITerminatedAug 25, 2021Haloperidol Decanoate Injection 100 mg/mLTeva Pharmaceuticals USA · D-0732-2021Class IITerminatedAug 25, 2021Amikacin Sulfate Injection USP 1 gram/4mLTeva Pharmaceuticals USA · D-0733-2021Class IITerminatedAug 25, 2021Idarubicin Hydrochloride Injection 20 mg/20 mLTeva Pharmaceuticals USA · D-0734-2021Class IITerminatedAug 25, 2021Vecuronium Bromide for Injection 10 mgTeva Pharmaceuticals USA · D-0735-2021Class IITerminatedAug 25, 2021Leucovorin Calcium for InjectionTeva Pharmaceuticals USA · D-0737-2021Class IITerminatedAug 25, 2021Epoprostenol Sodium for InjectionTeva Pharmaceuticals USA · D-0738-2021Class IITerminatedAug 25, 2021Norepinephrine Bitartrate InjectionTeva Pharmaceuticals USA · D-0739-2021Class IITerminatedAug 25, 2021Adenosine InjectionTeva Pharmaceuticals USA · D-0740-2021Class IITerminatedAug 25, 2021Metoclopramide Injection USPTeva Pharmaceuticals USA · D-0741-2021Class IITerminatedAug 25, 2021Alprostadil Injection USPTeva Pharmaceuticals USA · D-0742-2021
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Octreotide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.